Post marketing surveillance of Edirol

Post marketing surveillance of Edirol - Post marketing surveillance of Edirol

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018333

Enrollment

3000

Registered

2015-08-01

Start date

2011-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have no previous treatment with Edirol for osteoporosis

Exclusion criteria

Exclusion criteria: No criteria

Design outcomes

Primary

Measure	Time frame
Adverse reaction incidence	—

Countries

Japan

Contacts

Public ContactMakoto Nomura

Chugai Pharmaceutical Co.Ltd Pharmacovigilance Dept

nomuramkt@chugai-pharm.co.jp03-3273-0905

Outcome results